Meyka Pro banner
Cawachi Limited

Cawachi Limited Fundamental Analysis (JPX: 2664.T)

2664.TJPX
HealthcareMedical - Pharmaceuticals
¥3760.00
¥40.00(1.05%)
Japanese Market opens in 17h 10m

Cawachi Limited Fundamental Analysis (JPX: 2664.T)

Cawachi Limited (JPX: 2664.T) shows weak financial fundamentals with a PE ratio of 25.96, profit margin of 1.14%, and ROE of 2.82%. The company generates $285.4B in annual revenue with weak year-over-year growth of -1.15%.

Key Strengths

Cash Position52.79%
PEG Ratio-0.83
Current Ratio1.51

Areas of Concern

ROE2.82%
Operating Margin2.43%
We analyze 2664.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 28.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
28.6/100

We analyze 2664.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

2664.T struggles to generate sufficient returns from assets.

ROA > 10%
1.61%

Valuation Score

Moderate

2664.T shows balanced valuation metrics.

PE < 25
25.96
PEG Ratio < 2
-0.83

Growth Score

Weak

2664.T faces weak or negative growth trends.

Revenue Growth > 5%
-1.15%
EPS Growth > 10%
-34.48%

Financial Health Score

Excellent

2664.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.14
Current Ratio > 1
1.51

Profitability Score

Weak

2664.T struggles to sustain strong margins.

ROE > 15%
281.96%
Net Margin ≥ 15%
1.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is 2664.T Expensive or Cheap?

P/E Ratio

2664.T trades at 25.96 times earnings. This indicates a fair valuation.

25.96

PEG Ratio

When adjusting for growth, 2664.T's PEG of -0.83 indicates potential undervaluation.

-0.83

Price to Book

The market values Cawachi Limited at 0.74 times its book value. This may indicate undervaluation.

0.74

EV/EBITDA

Enterprise value stands at 9.53 times EBITDA. This is generally considered low.

9.53

How Well Does 2664.T Make Money?

Net Profit Margin

For every $100 in sales, Cawachi Limited keeps $1.14 as profit after all expenses.

1.14%

Operating Margin

Core operations generate 2.43 in profit for every $100 in revenue, before interest and taxes.

2.43%

ROE

Management delivers $2.82 in profit for every $100 of shareholder equity.

2.82%

ROA

Cawachi Limited generates $1.61 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.61%

Following the Money - Real Cash Generation

Operating Cash Flow

Cawachi Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Cawachi Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

2664.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

25.96

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.83

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.74

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.30

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.51

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How 2664.T Stacks Against Its Sector Peers

Metric2664.T ValueSector AveragePerformance
P/E Ratio25.9631.61 Better (Cheaper)
ROE2.82%541.00% Weak
Net Margin1.14%30180.00% Weak
Debt/Equity0.140.54 Strong (Low Leverage)
Current Ratio1.515.70 Neutral
ROA1.61%-8.00% (disorted) Weak

2664.T outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cawachi Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-0.13%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-55.05%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-42.01%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ